Riverside Partners
Founded in 1988, Riverside Partners seeks investments in growing middle-market healthcare- and technology-oriented companies. Based in Boston, the firm typically invest in companies with revenues between $10 million and $100 million. Companies in its healthcare portfolio include BioAgilytix Labs, a contract bioanalytical laboratory specializing in large molecule biologic drugs; Enovate Medical, a designer and manufacturer of clinical workstations sold to hospitals; HealthDrive, a provider of multi-specialty, on-site healthcare services to residents of extended care facilities; and Dominion Diagnostics, a provider of clinical quantitative urine drug testing and medication monitoring.
